Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Not Confirmed
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Not Confirmed
Not Confirmed
04-05 June, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Industry Trade Show
Not Confirmed
03-05 June, 2026
Peptide Therapeutics F...Peptide Therapeutics Forum 2026
Industry Trade Show
Not Confirmed
04-05 June, 2026
Digital content

01 Jun 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/06/01/3304175/0/en/actuate-therapeutics-announces-asco-poster-presentations-demonstrating-compelling-clinical-and-biomarker-data-for-elraglusib-in-first-line-metastatic-pancreatic-cancer.html

18 May 2026
// BIOSPACE
https://www.biospace.com/drug-development/can-revolutions-miracle-pancreatic-cancer-drug-be-topped-immuneering-actuate-say-yes

11 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/11/3291744/0/en/actuate-therapeutics-announces-fda-clearance-of-ind-for-oral-elraglusib-and-strategic-initiatives-to-advance-the-elraglusib-development-program.html

06 May 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/05/06/3288846/0/en/actuate-therapeutics-announces-key-appointment-of-industry-veteran-to-board-of-directors.html

14 Apr 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/04/14/3273413/0/en/Actuate-Therapeutics-Announces-Nature-Medicine-Publication-of-Clinical-Trial-Results-Showing-Doubling-of-the-Rate-of-Survival-with-Elraglusib-Plus-Chemotherapy-in-Previously-Untrea.html

24 Mar 2026
// PHARMIWEB
https://www.pharmiweb.com/press-release/2026-03-24/actuate-therapeutics-poised-for-potential-200mplus-pediatric-priority-review-vouchers-and-transformat
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE